Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.
Blood Cancer J
; 7(3): e549, 2017 03 31.
Article
in En
| MEDLINE
| ID: mdl-28362441
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gene Expression
/
Cell Cycle Checkpoints
/
Enhancer of Zeste Homolog 2 Protein
/
Multiple Myeloma
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Blood Cancer J
Year:
2017
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States